Vivos Therapeutics (VVOS) PT Raised to $2.90 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts VVOS Hot Sheet
Price: $0.31 +6.90%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Ascendiant Capital analyst Lucas Ward raised the price target on Vivos Therapeutics (NASDAQ: VVOS) to $2.90 (from $2.80) while maintaining a Buy rating.
You May Also Be Interested In
- Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,200 at Susquehanna
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
